These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2128420)

  • 1. Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
    Fears R; Ferres H; Greenwood HC
    Thromb Res; 1990 Nov; 60(4):259-68. PubMed ID: 2128420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction in the platelet activation induced by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex.
    Abdelouahed M; Emadi S; Elalamy I; Samama MM; Hatmi M
    Platelets; 1997; 8(2-3):135-41. PubMed ID: 20297934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction in the platelet activation induced by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex.
    Platelets; 1997 Apr; 8(2):135-42. PubMed ID: 16793641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates.
    Terres W; Umnus S; Mathey DG; Bleifeld W
    Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators.
    O'Connor CM; Meese RB; McNulty S; Lucas KD; Carney RJ; LeBoeuf RM; Maddox W; Bethea CF; Shadoff N; Trahey TF; Heinsimer JA; Burks JM; O'Donnell G; Krucoff MW; Califf RM
    Am J Cardiol; 1996 Apr; 77(10):791-7. PubMed ID: 8623729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of recombinant staphylokinase and streptokinase on platelet aggregation.
    Abdelouahed M; Hatmi M; Helft G; Emadi S; Elalamy I; Samama MM
    Thromb Haemost; 1997 May; 77(5):815-7. PubMed ID: 9184383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation.
    Berridge DC; Burgess-Wilson ME; Westby JC; Hopkinson BR; Makin GS
    Br J Surg; 1989 Oct; 76(10):1026-30. PubMed ID: 2513082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
    Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
    Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
    Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
    Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A european multicenter and randomized study of APSAC versus streptokinase in myocardial infarction].
    Charbonnier B; Cribier A; Monassier JP; Favier JP; Materne P; Brochier ML; Letac B; Hanssen M; Sacrez A; Kulbertus H
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1565-71. PubMed ID: 2510677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit.
    Ohlstein EH; Storer B; Fujita T; Shebuski RJ
    Thromb Res; 1987 May; 46(4):575-85. PubMed ID: 3112993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.